Strategy

Serenus Biotherapeutics is building a broad portfolio of drugs spanning multiple therapeutic areas for both chronic and infectious diseases already approved in highly regulated U.S., European, and Japanese markets that address unmet medical needs in Sub-Saharan Africa.

Serenus will be the ideal conduit to navigate the quagmire between accessibility to life saving drugs and protecting intellectual property of partner companies by offering an African Accessibility Platform from which to work.

By assembling a team with deep expertise and relationships in Africa and a proven track record in both developed and emerging biopharmaceutical markets, Serenus is a partner of choice for in-licensing opportunities for Biopharmaceutical companies seeking to expand access to their novel therapeutic agents into the Sub-Saharan African healthcare system.